An Update on the Systemic Therapy of Malignant Salivary Gland Cancers: Role of Chemotherapy and Molecular Targeted Agents
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
4
Page:
543-551
Author(s):
M. Agulnik and L. L. Siu
Characteristic Alterations of Nuclear Structure and Chromatin Organisation of Cancer Cells Addressed by Proteome Analysis**
Journal:
Current Proteomics
Volume:
1
Page:
113-129
Author(s):
Christopher Gerner
Proteomic Approaches in Plant Biology
Journal:
Current Proteomics
Volume:
1
Page:
131-144
Author(s):
Birgit Kersten, Tanja Feilner, Philipp Angenendt, Patrick Giavalisco, Wolfram Brenner and Lukas Burkle
New Approach to Cancer Therapy: The Application of Signal Transduction to Anti-Cancer Drug
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
3
Page:
119-131
Author(s):
Shinji Osada and Shigetoyo Saji
Signal Transduction Inhibitors in the Treatment of Breast Cancer
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
3
Page:
201-216
Author(s):
Rita Nahta, Gabriel N. Hortobagyi and Francisco J. Esteva
Peroxisome Proliferator Activated Receptor-Gamma Ligands as Potent Antineoplastic Agents
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
3
Page:
239-251
Author(s):
S. Theocharis, A. Margeli and G. Kouraklis
Disruption of Cell Death Signaling in Cancer: Impact on Disease Prognosis and Response to Therapy
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
3
Page:
319-326
Author(s):
Dilek Guner, Claus Belka and Peter T. Daniel
Anti-Epidermal Growth Factor Receptor Strategies to Enhance Radiation Action
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
3
Page:
327-333
Author(s):
G. Lammering
Death Receptor Ligands: New Strategies for Combined Treatment with Ionizing Radiation
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
3
Page:
334-342
Author(s):
Patrizia Marini and Claus Belka
Hypoxic Radiosensitizers and Hypoxic Cytotoxins in Radiation Oncology
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
3
Page:
364-374
Author(s):
Martin Weinmann, Stefan Welz and Michael Bamberg